Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Doyle

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
The Prostate|September 25, 2004
A phase II trial of imatinib mesylate in patients with prostate specific antigen progression after local therapy for prostate cancerKamakshi Rao, Susan Goodin, Michael J Levitt, et al.
Vaccine|June 7, 2017
The effect of timing of influenza vaccination and sample collection on antibody titers and responses in the agedRaj K Kurupati, Andrew Kossenkoff, Senthil Kannan, et al.
Marine Pollution Bulletin|August 28, 2020
Ingestion of anthropogenic debris by migratory barnacle geese Branta leucopsis on a remote north-eastern Atlantic islandNeil E Coughlan, Susan Doyle, Connie Baker-Arney, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 17, 2018
Spirometry and Impulse Oscillometry in Preschool Children: Acceptability and Relationship to Maternal Smoking in PregnancyMeyer Kattan, Leonard B Bacharier, George T O'Connor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2002
Characterization of a novel prostate-specific antigen-activated peptide-doxorubicin conjugate in patients with prostate cancerRobert S DiPaola, John Rinehart, John Nemunaitis, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
The Prostate|September 25, 2004
A phase II trial of imatinib mesylate in patients with prostate specific antigen progression after local therapy for prostate cancerKamakshi Rao, Susan Goodin, Michael J Levitt, et al.
Vaccine|June 7, 2017
The effect of timing of influenza vaccination and sample collection on antibody titers and responses in the agedRaj K Kurupati, Andrew Kossenkoff, Senthil Kannan, et al.
Marine Pollution Bulletin|August 28, 2020
Ingestion of anthropogenic debris by migratory barnacle geese Branta leucopsis on a remote north-eastern Atlantic islandNeil E Coughlan, Susan Doyle, Connie Baker-Arney, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 17, 2018
Spirometry and Impulse Oscillometry in Preschool Children: Acceptability and Relationship to Maternal Smoking in PregnancyMeyer Kattan, Leonard B Bacharier, George T O'Connor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2002
Characterization of a novel prostate-specific antigen-activated peptide-doxorubicin conjugate in patients with prostate cancerRobert S DiPaola, John Rinehart, John Nemunaitis, et al.
Pageof 4